"10.1371_journal.pone.0127950","plos one","2015-06-04T00:00:00Z","Anna B Cope; Kimberly A Powers; JoAnn D Kuruc; Peter A Leone; Jeffrey A Anderson; Li-Hua Ping; Laura P Kincer; Ronald Swanstrom; Victoria L Mobley; Evelyn Foust; Cynthia L Gay; Joseph J Eron; Myron S Cohen; William C Miller","Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America; Division of Infectious Diseases, Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America; Bristol-Myers Squibb, Lawrenceville, New Jersey, United States of America; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, North Carolina, United States of America; Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America; UNC Center for AIDS Research, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, North Carolina, United States of America; North Carolina Department of Health and Human Services, Division of Public Health, Raleigh, North Carolina, United States of America","Conceived and designed the experiments: AC KP WM. Performed the experiments: AC. Analyzed the data: AC. Wrote the paper: AC KP WM JK PL JA VM EF CG JE MC. Conducted phylogenetic analyses for CHAVI-001 enrollees: JA L-HP LK RS. Facilitated collection of data from the STAT program: JK PL VM EF MC. Implemented CHAVI-001 study protocol and data collection: JK CG JE MC.","MC serves on the Roche Molecular Systems advisory board and the Bill and Melinda Gates Foundation HIV external advisory panal. MC has previously served on the advisory board for Janssen Global Services. MC also is employed through the University of North Carolina (UNC). JE and CG received research support through UNC from Bristol-Myers Squibb (BMS). CG has also received support from Abbot Laboratories, Janssen Research & Development, Gilead Sciences, and Argos Therapeutics. JE has received additional support from Merck, BMS, Glaxosmithkline (GSK) and ViiV Healthcare and is an ad hoc consultant to BMS, Gilead Sciences, Janssen, Merck, GSK and ViiV Healthcare. PL receives support and is a speaker for Abbott Diagnostics. RS receives grant support from National Institutes of Health (NIH). JK is employed by NIH grants through UNC and received support to travel to a scientific meeting for this study through NIH funding. JA is an employee of and holds stock in BMS. For the remaining authors, no competing interests were declared. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2015","06","Anna B Cope","ABC",14,FALSE,3,1,1,11,TRUE,TRUE,FALSE,0,NA,FALSE
